DAVITA INC. overview

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call PR Newswire DENVER, Jan. 30, 2025 DENVER , Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as...

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health PR Newswire DENVER, Jan. 15, 2025 DENVER , Jan. 15, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a purpose "to give life" in 2000, DaVita has focused its efforts to improve clinical outcomes, enhance quality of life for patients and be a force for positive change for the...

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires PR Newswire LOS ANGELES, Jan. 9, 2025 LOS ANGELES , Jan. 9, 2025 /PRNewswire/ -- DaVita , a comprehensive kidney care provider, has activated its emergency response plan as devastating wildfires spread across Southern California . DaVita's emergency response plan includes: Accounting for patients and teammates (employees), assessing facilities in the affected areas and identifying safe shelters....

DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 PR Newswire DENVER, Nov. 8, 2024 DENVER , Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason , will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST ( 3:30 pm EST ). To view the live webcast, visit the UBS page here...

DaVita Inc. 3rd Quarter 2024 Results PR Newswire DENVER, Oct. 29, 2024 DENVER , Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said Javier Rodriguez , CEO of DaVita Inc. "And, in light of recent severe storms, I am grateful for the remarkable resilience of our...

DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program PR Newswire DENVER, Oct. 28, 2024 The program aims to bring together a supportive network for people dealing with chronic health challenges for themselves and their loved ones DENVER , Oct. 28, 2024 /PRNewswire/ -- The DaVita Giving Foundation today announced an investment in the National Kidney Foundation (NKF)'s PEERS program , a program that provides social and emotional support for...

DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 PR Newswire DENVER and SAN DIEGO, Oct. 23, 2024 DENVER and SAN DIEGO , Oct. 23, 2024 /PRNewswire/ -- DaVita Clinical Research (DCR), a leading innovator in kidney care research and wholly owned subsidiary of DaVita Inc., will present the results of five innovative research projects at the American Society of Nephrology (ASN)'s annual Kidney Week meeting, which is currently underway in San Diego, CA....

DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program PR Newswire DENVER, Oct. 22, 2024 Nephrologists drive transformative outcomes through government's coordinated care program serving high-need patients DENVER , Oct. 22, 2024 /PRNewswire/ -- DaVita today announced performance year one clinical outcomes achieved in partnership with nearly 1,300 nephrologists across the U.S. through value-based care arrangements designed to enhance the lives of...